Share Prices & Company Research

Stockbroking

EKF Diagnostics Holdings

Current Price 32.27p Bid 30.50p Ask 33.00p Change 0.00%
Last Updated: 22/11/2019 17:41. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

EKF Diagnostics Holdings plc (formerly International Brand Licensing plc) is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

Financial Highlights Year Ended 31/12/2018

Turnover
£42.54m
Operating Profit
£12.20m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
14.37

Key Personnel

Julian Huw Baines
Chief Executive Officer
Richard Anthony Evans
Group Finance Director
Christopher Harwood Bernard Mills
Non-Executive Chairman
Adam Reynolds
Non-Executive Director
Carl Dominic Contadini
Non-Executive Director

Stock Details

EPIC
EKF
ISIN
GB0031509804
Shares in Issue
455,163,766
Market cap
£144.51m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
31.75p
Bid Price
30.50p
Ask Price
33.00p
Volume
230769
Change Today
0.00p
% Change Today
0.00%
Open
32.85p
Previous Close
31.75p
Intraday High
32.85p
Intraday Low
30.83p
52 Week High
37.70p
52 Week Low
23.85p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

EKF Diagnostics Holdings Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
12.5
12.1
Intangible Assets & Goodwill
41.8
43.6
Investments & Other Non-Current Assets
3.3
0.2
Total Non-Current Assets
57.6
55.9
Inventory
6.1
5.6
Trade & Receivables
7.4
7.4
Cash & Receivables
10.3
8.2
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
81.4
77.2

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
13.6
12.3
Long Term Liabilities
3.9
4.3
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
17.5
16.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
63.9
60.5

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
4.5
4.6
Minority Interests
0.4
0.5
Retained Earnings
52.5
50.4
Share Premium Account
0.0
0.0
Other Equity
6.5
5.0
Total Equity
63.9
60.5

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
8.3
9.1
Cashflow Before Financing
3.4
7.0
Increase / Decrease in Cash
1.9
0.6

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
42.5
41.6
Cost of Sales
19.9
18.7
Gross Profit
22.7
22.9
Operating Profit
12.2
4.7
Pre-Tax Profit
12.2
4.3
Profit / Loss for the Year
10.3
2.9
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.